This page provides information and guidance on lung cancer for health care professionals.
Information for patients can be found on our patient hub.
If would like further information on the Lung CSG please click here to contact us.
The National Optimal Pathway for lung cancer was developed in conjunction with the lung CSG to support the implementation of the the Single Cancer Pathway (SCP) in Wales.
The Welsh Thoracic Oncology Group (WTOG) has revised the Lung Cancer National Optimal Pathway (NOPLC). This second edition (2022) of the NOLCP reflects the changing developments in the treatment of lung cancer since the NOLCP was first described. A standardised approach to molecular and genetic testing of biopsies allows patients with both early and advanced stage lung cancer to benefit from an increasing range of novel therapies and improve access to clinical trials.
Contact details can be accessed via the NHS Wales Global address list. If you do not have access to this please click here to contact us.
Health Board/MDT | MDT Lead | MDT Frequency |
Aneurin Bevan UHB | Dr Mat Jones |
Thursdays 11:30 am Weekly |
Betsi Cadwaladr UHB – Ysbyty Glan Clwyd | Dr Sakkarai Ambalavanan |
Wednesdays 11am Weekly |
Betsi Cadwaladr UHB – Ysbyty Gwynedd | Dr Ali Thahseen |
Tuesdays 1pm Weekly |
Betsi Cadwaladr UHB – Ysbyty Wrexham Maelor | Chair is shared by the team |
Wednesdays 8am Weekly |
Cardiff & Vale UHB | Dr Diane Parry |
Thursdays 12:15pm Weekly |
Cwm Taf UHB – Prince Charles | Dr Alex Jones |
Wednesdays 8:30am Weekly |
Cwm Taf UHB – Princess of Wales | Dr Emma Watkins |
Thursdays 8:30pm Weekly |
Cwm Taf UHB – Royal Glamorgan | Dr Sinan Eccles |
Tuesdays 8:30am Weekly |
Hywel Dda UHB | Dr Gareth Collier |
Thursdays 1pm Weekly |
Swansea Bay UHB | Dr Emrys Evans |
Mondays 9:30am Weekly |
The Welsh Thoracic Oncology Group Meeting 2022 took place on 1st October 2021. To access the recording please click here to contact us.